NEW ORALLY ACTIVE MONOAMINE OXIDASE (MAO) INHIBITORS.
D001921:Brain / Q000201:enzymology*; D006834:Hydrazines; D007211:Indoles; D008099:Liver / Q000201:enzymology*; D008995:Monoamine Oxidase; D008996:Monoamine Oxidase Inhibitors; D009638:Norepinephrine; D010600:Pharmacology; D010624:Phenelzine; D051381:Rats; D012106:Research; D012110:Reserpine; D012701:Serotonin; D013154:Spleen
D006834:Hydrazines; D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; C084776:pheniprazine; D012110:Reserpine; D008995:Monoamine Oxidase; D010624:Phenelzine; D009638:Norepinephrine
BRAIN ENZYMOLOGY; EXPERIMENTAL LAB STUDY; INDOLES; LIVER ENZYMOLOGY; MONOAMINE OXIDASE INHIBITORS; NOREPINEPHRINE; PHARMACOLOGY; PHENELZINE; PHENIPRAZINE; RATS; RESERPINE; SEROTONIN; SPLEEN